Bio-Rad Laboratories (NYSE:BIO.B) Sees Unusually-High Trading Volume – Time to Buy?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares saw unusually-strong trading volume on Wednesday . Approximately 218 shares traded hands during trading, a decline of 22% from the previous session’s volume of 280 shares.The stock last traded at $359.22 and had previously closed at $357.05.

Bio-Rad Laboratories Price Performance

The company has a 50-day simple moving average of $336.46 and a 200-day simple moving average of $329.04. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $2.01 earnings per share for the quarter. The business had revenue of $649.73 million during the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.